These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15460964)

  • 21. [Testing HPV vaccine is an ethical dilemma. Can we afford not to offer vaccination against an infection which is a cause of cancer?].
    Dillner J
    Lakartidningen; 2003 Oct; 100(43):3390-1. PubMed ID: 14626766
    [No Abstract]   [Full Text] [Related]  

  • 22. Effectiveness of preventive human papillomavirus vaccination.
    Lehtinen M; Paavonen J
    Int J STD AIDS; 2003 Dec; 14(12):787-92. PubMed ID: 14678583
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of carcinoma of cervix with human papillomavirus vaccine.
    Gavarasana S; Kalasapudi RS; Rao TD; Thirumala S
    Indian J Cancer; 2000; 37(2-3):57-66. PubMed ID: 11876611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Human papillomavirus: a vaccine against cervical carcinoma uterine].
    Franceschi S
    Epidemiol Prev; 2002; 26(3):140-4. PubMed ID: 12197051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A vaccine against papillomavirus infections and cancer].
    Lehtinen M; Apter D; Heikkilä R; Heino P; Idänpään-Heikkilä I; Rimpilä K; Malm C; Zilliacus R
    Duodecim; 2002; 118(13):1397-404. PubMed ID: 12239887
    [No Abstract]   [Full Text] [Related]  

  • 26. Parental acceptance of the human papillomavirus vaccine.
    Olshen E; Woods ER; Austin SB; Luskin M; Bauchner H
    J Adolesc Health; 2005 Sep; 37(3):248-51. PubMed ID: 16109349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrating HPV vaccination into your practice: overcoming common barriers.
    Levy B
    J Fam Pract; 2009 Sep; 58(9 Suppl HPV):S11-3. PubMed ID: 19744420
    [No Abstract]   [Full Text] [Related]  

  • 28. [HPV vaccination--a possibility for prevention of cervical cancer].
    Paavonen J
    Duodecim; 2002; 118(21):2159-60. PubMed ID: 12486951
    [No Abstract]   [Full Text] [Related]  

  • 29. Human papillomavirus vaccines in development: if they're successful in clinical trials, how will they be implemented?
    Shaw AR
    Gynecol Oncol; 2005 Dec; 99(3 Suppl 1):S246-8. PubMed ID: 16213009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human papillomavirus infection: an old disease, a new vaccine.
    Giles M; Garland S
    Aust N Z J Obstet Gynaecol; 2006 Jun; 46(3):180-5. PubMed ID: 16704468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaccinating women against premature death: summary of an International Workshop, Helsinki, Finland, 10.01.2000.
    Lehtinen M; Dillner J; Paavonen J
    Vaccine; 2001 Jan; 19(11-12):1347-52. PubMed ID: 11252250
    [No Abstract]   [Full Text] [Related]  

  • 32. Fostering acceptance of human papillomavirus vaccines.
    Dekker AH
    J Am Osteopath Assoc; 2006 Mar; 106(3 Suppl 1):S14-8. PubMed ID: 16729556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is vaccination against human papillomavirus a possibility?
    Galloway DA
    Lancet; 1998; 351 Suppl 3():22-4. PubMed ID: 9652717
    [No Abstract]   [Full Text] [Related]  

  • 34. CDC recommends expensive vaccine for all girls aged 11-12.
    Tanne J
    BMJ; 2006 Jul; 333(7559):114. PubMed ID: 16840454
    [No Abstract]   [Full Text] [Related]  

  • 35. HPV vaccines.
    Greenwood K
    J Fam Plann Reprod Health Care; 2005 Jan; 31(1):81; author reply 81. PubMed ID: 15720869
    [No Abstract]   [Full Text] [Related]  

  • 36. Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data.
    Ali H; Donovan B; Wand H; Read TR; Regan DG; Grulich AE; Fairley CK; Guy RJ
    BMJ; 2013 Apr; 346():f2032. PubMed ID: 23599298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Perspectives for the development of vaccines and immunotherapy against cervico-uterine cancer].
    Guzmán-Rojas L; Alcocer-González JM; Madrid-Marina V
    Salud Publica Mex; 1998; 40(1):38-46. PubMed ID: 9567657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mucosal vaccination with a recombinant Salmonella typhimurium expressing human papillomavirus type 16 (HPV16) L1 virus-like particles (VLPs) or HPV16 VLPs purified from insect cells inhibits the growth of HPV16-expressing tumor cells in mice.
    Revaz V; Benyacoub J; Kast WM; Schiller JT; De Grandi P; Nardelli-Haefliger D
    Virology; 2001 Jan; 279(1):354-60. PubMed ID: 11145916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention strategies of cervical cancer in the HPV vaccine era.
    Bosch X; Harper D
    Gynecol Oncol; 2006 Oct; 103(1):21-4. PubMed ID: 16919714
    [No Abstract]   [Full Text] [Related]  

  • 40. Papillomavirus-like particle vaccines for cervical cancer.
    Schiller JT
    Mol Med Today; 1999 May; 5(5):209-15. PubMed ID: 10322313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.